Revenue, last quarter
$9.1M
+29.8% vs same quarter last year
Net income
−$6.4M
+3.4% vs same quarter last year
EPS, diluted
−$0.42
+32.3% vs same quarter last year
Operating cash flow
−$1.4M
+62.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $41.7M | −$10.5M |
| FY24 | $37.3M | −$17.8M |
| FY23 | $34.1M | −$20.1M |
| FY22 | $28.7M | −$640K |
| FY21 | $24M | −$37.7M |
| FY20 | $18.8M | −$11M |
| FY19 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −27.2% | −25.3% |
| FY24 | −46.1% | −47.6% |
| FY23 | −66.6% | −59.1% |
| FY22 | −64.8% | −2.2% |
| FY21 | −104.8% | −156.9% |
| FY20 | −51% | −58.3% |
| FY19 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$13.4M |
| FY24 | −$10.3M |
| FY23 | −$24.9M |
| FY22 | −$16.2M |
| FY21 | - |
| FY20 | - |
| FY19 | - |
- Biofrontera
- Healthcare median
Show the numbers
| Year | Biofrontera | Healthcare median |
|---|---|---|
| FY25 | −25.3% | −30.6% |
| FY24 | −47.6% | −47% |
| FY23 | −59.1% | −58% |
| FY22 | −2.2% | −80.4% |
| FY21 | −156.9% | −71.8% |
| FY20 | −58.3% | −62.2% |
| FY19 | - | −46.2% |